Cheryl Murphy

1.7k total citations
27 papers, 1.4k citations indexed

About

Cheryl Murphy is a scholar working on Infectious Diseases, Molecular Biology and Parasitology. According to data from OpenAlex, Cheryl Murphy has authored 27 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 11 papers in Molecular Biology and 11 papers in Parasitology. Recurrent topics in Cheryl Murphy's work include Amoebic Infections and Treatments (12 papers), Parasitic Infections and Diagnostics (11 papers) and Immunotherapy and Immune Responses (8 papers). Cheryl Murphy is often cited by papers focused on Amoebic Infections and Treatments (12 papers), Parasitic Infections and Diagnostics (11 papers) and Immunotherapy and Immune Responses (8 papers). Cheryl Murphy collaborates with scholars based in United States, Switzerland and Australia. Cheryl Murphy's co-authors include J. I. Ravdin, William A. Petri, Roger Smith, Paul H. Schlesinger, Richard L. Guerrant, Craig L. Slingluff, Gina R. Petroni, Leland W.K. Chung, Gary Balian and Haiyen E. Zhau and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and The Journal of Immunology.

In The Last Decade

Cheryl Murphy

27 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl Murphy United States 17 673 517 478 441 390 27 1.4k
C. Kelly United Kingdom 19 121 0.2× 94 0.2× 101 0.2× 357 0.8× 225 0.6× 34 1.2k
Lauren B. Rodda United States 9 181 0.3× 286 0.6× 58 0.1× 275 0.6× 707 1.8× 13 1.2k
Myriam Bodescot France 12 237 0.4× 52 0.1× 130 0.3× 476 1.1× 172 0.4× 18 1.3k
Sofía Casares United States 25 171 0.3× 61 0.1× 147 0.3× 504 1.1× 1.3k 3.2× 70 2.1k
Michael Heike Germany 19 135 0.2× 26 0.1× 247 0.5× 700 1.6× 542 1.4× 58 1.6k
Paula S. Norris United States 20 134 0.2× 76 0.1× 99 0.2× 528 1.2× 1.1k 2.7× 30 2.0k
Daniel C. Edelman United States 17 198 0.3× 47 0.1× 77 0.2× 393 0.9× 53 0.1× 34 903
M Chen United States 9 197 0.3× 209 0.4× 21 0.0× 214 0.5× 126 0.3× 9 710
Vanitha S. Raman United States 18 187 0.3× 141 0.3× 51 0.1× 355 0.8× 1.1k 2.7× 22 2.0k
Audrey Romano United States 19 110 0.2× 265 0.5× 31 0.1× 474 1.1× 418 1.1× 29 1.9k

Countries citing papers authored by Cheryl Murphy

Since Specialization
Citations

This map shows the geographic impact of Cheryl Murphy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl Murphy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl Murphy more than expected).

Fields of papers citing papers by Cheryl Murphy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl Murphy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl Murphy. The network helps show where Cheryl Murphy may publish in the future.

Co-authorship network of co-authors of Cheryl Murphy

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl Murphy. A scholar is included among the top collaborators of Cheryl Murphy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl Murphy. Cheryl Murphy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, Cheryl, Eric M. Bachelder, & Kristy M. Ainslie. (2025). Mast cell activators as adjuvants for intranasal mucosal vaccines. International Journal of Pharmaceutics. 672. 125300–125300. 1 indexed citations
2.
Murphy, Cheryl, Eliza A. Hawkes, Fiona Chionh, & Geoffrey Chong. (2016). Durable remission of both multicentric Castleman's disease and Kaposi's sarcoma with valganciclovir, rituximab and liposomal doxorubicin in an HHV-8-positive, HIV-negative patient. Journal of Clinical Pharmacy and Therapeutics. 42(1). 111–114. 13 indexed citations
3.
Parakh, Sagun, et al.. (2014). Response to MAPK pathway inhibitors in BRAF V600M-mutated metastatic melanoma. Journal of Clinical Pharmacy and Therapeutics. 40(1). 121–123. 13 indexed citations
4.
Shada, Amber L., Cheryl Murphy, Dandan Sun, et al.. (2013). MicroRNAs induced in melanoma treated with combination targeted therapy of Temsirolimus and Bevacizumab. Journal of Translational Medicine. 11(1). 218–218. 19 indexed citations
5.
Erdag, Gulsun, Cheryl Murphy, Donna H. Deacon, et al.. (2011). VEGFR‐2 expression in human melanoma: Revised assessment. International Journal of Cancer. 129(12). 2807–2815. 26 indexed citations
6.
Slingluff, Craig L., Gina R. Petroni, Mark E. Smolkin, et al.. (2010). Immunogenicity for CD8+ and CD4+ T Cells of 2 Formulations of an Incomplete Freund's Adjuvant for Multipeptide Melanoma Vaccines. Journal of Immunotherapy. 33(6). 630–638. 24 indexed citations
7.
Chianese‐Bullock, Kimberly A., William P. Irvin, Gina R. Petroni, et al.. (2008). A Multipeptide Vaccine is Safe and Elicits T-cell Responses in Participants With Advanced Stage Ovarian Cancer. Journal of Immunotherapy. 31(4). 420–430. 85 indexed citations
8.
Slingluff, Craig L., Gina R. Petroni, Kimberly A. Chianese‐Bullock, et al.. (2007). Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting. Clinical Cancer Research. 13(21). 6386–6395. 133 indexed citations
9.
10.
Slingluff, Craig L., Élyse Y. Bissonnette, S. Hibbitts, et al.. (2004). Immunological results of a phase II randomized trial of multipeptide vaccines for melanoma. Journal of Clinical Oncology. 22(14_suppl). 7503–7503. 2 indexed citations
11.
12.
Thomas, Christopher, et al.. (1993). Generation and Pathogenicity of an NB-tropic SL3-3 Murine Leukemia Virus. Virology. 193(2). 1013–1017. 10 indexed citations
13.
Ravdin, J. I. & Cheryl Murphy. (1992). Characterization of the Galactose‐Specific Binding Activity of a Purified Soluble Entamoeba histolytica Adherence Lectin. The Journal of Protozoology. 39(2). 319–323. 9 indexed citations
14.
Ravdin, J. I., Terry Jackson, William A. Petri, et al.. (1990). Association of Serum Antibodies to Adherence Lectin with Invasive Amebiasis and Asymptomatic Infection with Pathogenic Entamoeba histolytica. The Journal of Infectious Diseases. 162(3). 768–772. 88 indexed citations
15.
Ravdin, J. I., Pamela Stanley, Cheryl Murphy, & William A. Petri. (1989). Characterization of cell surface carbohydrate receptors for Entamoeba histolytica adherence lectin. Infection and Immunity. 57(7). 2179–2186. 53 indexed citations
16.
Ravdin, J. I., Cheryl Murphy, & Paul H. Schlesinger. (1988). The Cellular Regulation of Vesicle Exocytosis by Entamoeba histolytica1,2. The Journal of Protozoology. 35(1). 159–163. 16 indexed citations
17.
Petri, William A., Roger Smith, Paul H. Schlesinger, Cheryl Murphy, & J. I. Ravdin. (1987). Isolation of the galactose-binding lectin that mediates the in vitro adherence of Entamoeba histolytica.. Journal of Clinical Investigation. 80(5). 1238–1244. 230 indexed citations
18.
Petri, William A., et al.. (1987). Recognition of the galactose- or N-acetylgalactosamine-binding lectin of Entamoeba histolytica by human immune sera. Infection and Immunity. 55(10). 2327–2331. 51 indexed citations
19.
Ravdin, J. I., Paul H. Schlesinger, Cheryl Murphy, Ilya Y. Gluzman, & Donald J. Krogstad. (1986). Acid Intracellular Vesicles and the Cytolysis of Mammalian Target Cells by Entamoeba histolytica Trophozoites1. The Journal of Protozoology. 33(4). 478–486. 34 indexed citations
20.
Ravdin, J. I., et al.. (1985). Effect of Antagonists of Calcium and Phospholipase A on the Cytopathogenicity of Entamoeba histolytica. The Journal of Infectious Diseases. 152(3). 542–549. 96 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by C. Kelly Breakdown of academic impact, for papers by Lauren B. Rodda Breakdown of academic impact, for papers by Myriam Bodescot Breakdown of academic impact, for papers by Sofía Casares Breakdown of academic impact, for papers by Michael Heike Breakdown of academic impact, for papers by Paula S. Norris Breakdown of academic impact, for papers by Daniel C. Edelman Breakdown of academic impact, for papers by M Chen Breakdown of academic impact, for papers by Vanitha S. Raman Breakdown of academic impact, for papers by Audrey Romano
Rankless by CCL
2026